Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Introduction'Plasma HDL are small, dense, spherical lipid-protein com- plexes.They consist of -50% lipid and 50% protein.The major lipids are phospholipid (PL),2 cholesterol (C), choles- teryl esters (CE), and triglycerides (TG).The major proteins are apo A-I (Mr 28,000) and apo A-II (Mr 17,000).There are also a variety of minor but metabolically important apopro- teins in HDL called apo E and apo C (C-I, C-II, and C-Ill).HDL are heterogeneous and can be classified into larger, less dense HDL2 or smaller, denser HDL3.Although the major proportion of HDL is normally present in HDL3, individual variability in HDL levels in human populations usually re- flects different amounts of HDL2- A major known function of HDL is to act as a receptacle for excess PL and C, derived from cells or as by-products of lipolysis.These lipids are normally recycled from HDL to the liver in a process called reverse C transport (Fig. 1).This in- volves a direct pathway where C is transferred into HDL, then taken up by the liver, and also an indirect pathway, involving transfer of CE from HDL to VLDL, followed by uptake of VLDL in liver, or conversion of VLDL to LDL, and uptake of LDL by the liver.Another important function ofHDL is to act as a reservoir for apo E and C proteins.These proteins transfer onto TG-rich lipoproteins (e.g., during alimentary lipemia), providing a signal for the activation of lipolysis (the enzyme lipoprotein lipase [LPL] is activated by apo C-II) or targeting information that allows uptake of lipolyzed remnant lipoproteins by liver receptors (apo E is attracted to chylomicron or VLDL remnants and acts as a ligand for uptake of these parti- cles by liver receptors).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
Manninen, V. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410050061031 · Cited by 957
Coffee, Alcohol and Risk of Coronary Heart Disease among Japanese Men Living in Hawaii
Yano, K., Rhoads, G. G., & Kagan, A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708252970801 · Cited by 523
Plasma High-Density Lipoproteins
Tall, A. R., & Small, D. M. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811302992207 · Cited by 499
Self-citationGlass, C., Pittman, R. C., Weinstein, D. B., & Steinberg, D. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5435 · Cited by 491
Brown, M. L., Inazu, A., Hesler, C. B., Agellon, L. B., Mann, C., Whitlock, M. E., Marcel, Y. L., Milne, R. W., Koizumi, J., Mabuchi, H., et al. (1989) · Nature · doi:10.1038/342448a0 · Cited by 467
Self-citation
Cited by
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 860
Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Assmann, G., Schulte, H., von Eckardstein, A., & Huang, Y. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05852-2 · Cited by 698
Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux
Ji, Y., Jian, B., Wang, N., Sun, Y., Moya, M. D. L. L., Phillips, M. C., Rothblat, G. H., Swaney, J. B., & Tall, A. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20982 · Cited by 694
Self-citationEndothelial and Antithrombotic Actions of HDL
Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 655
Wang, N., Silver, D. L., Costet, P., & Tall, A. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005438200 · Cited by 570
Self-citationRegulation of Endothelial Nitric Oxide Synthase: Location, Location, Location
Shaul, P. W. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.155952 · Cited by 541
Srinivasan, S. R., Myers, L., & Berenson, G. S. (2002) · Diabetes · doi:10.2337/diabetes.51.1.204 · Cited by 480
Heinecke, J. W. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00173-7 · Cited by 466
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
Meshkani, R., & Adeli, K. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.018 · Cited by 458
Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice
Tward, A., Xia, Y.-R., Wang, X.-P., Shi, Y.-S., Park, C., Castellani, L. W., Lusis, A. J., & Shih, D. M. (2002) · Circulation · doi:10.1161/01.cir.0000023623.87083.4f · Cited by 455
Cholesterol transport between cells and high-density lipoproteins
Johnson, W. J., Mahlberg, F. H., Rothblat, G. H., & Phillips, M. C. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90132-2 · Cited by 443
Rigotti, A., Miettinen, H. E., & Krieger, M. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0037 · Cited by 439
Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins
Khovidhunkit, Memon, R. A., Feingold, K. R., & Grunfeld, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315611 · Cited by 403
Frick, M. H., Syvänne, M., Nieminen, M. S., Kauma, H., Majahalme, S., Virtanen, V., Kesäniemi, Y. A., Pasternack, A., & Taskinen, M.-R. (1997) · Circulation · doi:10.1161/01.cir.96.7.2137 · Cited by 388
Measurement of de novo hepatic lipogenesis in humans using stable isotopes.
Hellerstein, M. K., Christiansen, M., Kaempfer, S., Kletke, C., Wu, K., Reid, J. S., Mulligan, K., Hellerstein, N. S., & Shackleton, C. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115206 · Cited by 362
Atherosclerosis in Transgenic Mice Overexpressing Apolipoprotein A-II
Warden, C. H., Hedrick, C. C., Qiao, J.-H., Castellani, L. W., & Lusis, A. J. (1993) · Science · doi:10.1126/science.8332912 · Cited by 360
Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice
Tangirala, R. K., Tsukamoto, K., Chun, S. H., Usher, D., Puré, E., & Rader, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.17.1816 · Cited by 358
BLATTER, M., JAMES, R. W., MESSMER, S., BARJA, F., & POMETTA, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347
Schissel, S. L., Tweedie-Hardman, J., Rapp, J. H., Graham, G., Williams, K. J., & Tabas, I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118934 · Cited by 341
Kozarsky, K. F., Donahee, M. H., Glick, J. M., Krieger, M., & Rader, D. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.721 · Cited by 337
Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 336
Retinoids and retinoid-binding protein expression in rat adipocytes.
Tsutsumi, C., Okuno, M., Tannous, L., Piantedosi, R., Allan, M., Goodman, D. S., & Blaner, W. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46017-6 · Cited by 317
Uittenbogaard, A., Shaul, P. W., Yuhanna, I. S., Blair, A., & Smart, E. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11278 · Cited by 310
Laakso, M., Lehto, S., Penttilä, I., & Pyörälä, K. (1993) · Circulation · doi:10.1161/01.cir.88.4.1421 · Cited by 301
Chapman, M. J., Le Goff, W., Guerin, M., & Kontush, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp399 · Cited by 298
“Circulating HDL particles are highly heterogeneous in structure, intravascular metabolism, and anti-atherogenic activity, consisting primarily of two major subpopulations: large, light, cholesteryl ester (CE)-rich HDL2; and small, dense, CE-poor, protein-rich HDL3.”
BackgroundAgellon, L. B., Walsh, A., Hayek, T., Moulin, P., Jiang, X. C., Shelanski, S. A., Breslow, J. L., & Tall, A. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99088-5 · Cited by 298
Self-citationEndothelial dysfunction: Clinical implications
DREXLER, H. (1997) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(97)80030-8 · Cited by 293
Rashid, S., Watanabe, T., Sakaue, T., & Lewis, G. F. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00078-x · Cited by 277
Wang, N., Arai, T., Ji, Y., Rinninger, F., & Tall, A. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32920 · Cited by 275
Self-citationZeiher, A. M., Schächlinger, V, Hohnloser, S. H., Saurbier, B., & Just, H. (1994) · Circulation · doi:10.1161/01.cir.89.6.2525 · Cited by 259
van der Valk, M., Kastelein, J. J. P., Murphy, R. L., van Leth, F., Katlama, C., Horban, A., Glesby, M., Behrens, G., Clotet, B., Stellato, R. K., et al. (2001) · AIDS · doi:10.1097/00002030-200112070-00008 · Cited by 253
Recent advances in physiological lipoprotein metabolism
Ramasamy, I. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0358 · Cited by 235
“HDL2 is large, light, cholesteryl ester rich and HDL3 is small, dense cholesteryl ester poor and protein rich [241].”
BackgroundThe role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism
Trigatti, B., Rigotti, A., & Krieger, M. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200004000-00004 · Cited by 206
Greene, N. P., Martin, S. E., & Crouse, S. F. (2012) · Obesity · doi:10.1038/oby.2012.65 · Cited by 94
Jenkins, D. J. A., Chiavaroli, L., Wong, J. M. W., Kendall, C., Lewis, G. F., Vidgen, E., Connelly, P. W., Leiter, L. A., Josse, R. G., & Lamarche, B. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.092128 · Cited by 92
Distribution and Synthesis of Apolipoprotein J in the Atherosclerotic Aorta
Ishikawa, Y., Akasaka, Y., Ishii, T., Komiyama, K., Masuda, S., Asuwa, N., Choi-Miura, N.-H., & Tomita, M. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.4.665 · Cited by 86
Desrumaux, C. M., Mak, P. A., Boisvert, W. A., Masson, D., Stupack, D., Jauhiainen, M., Ehnholm, C., & Curtiss, L. K. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200281-jlr200 · Cited by 75
Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E
Fazio, S., Lee, Y. L., Ji, Z. S., & Rall, S. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116728 · Cited by 71
Krimbou, L., Tremblay, M., Davignon, J., & Cohn, J. S. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37273-4 · Cited by 53
Huang, Y., von Eckardstein, A., Wu, S., & Assmann, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118336 · Cited by 49
Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit
SEKIYA, N., Tanaka, N., Itoh, T., Shimada, Y., Goto, H., & TERASAWA, K. (1999) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(199905)13:3<192::aid-ptr412>3.0.co;2-2 · Cited by 34
New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells
Farokhi, S., Razavi, Z.-S., Mavaei, M., Shadab, A., Afkhami, H., & Sardarabadi, H. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-06113-8 · Cited by 27
Hannuksela, M. L., Brousseau, M. E., Meyn, S. M., Nazih, H., Bader, G., Shamburek, R. D., Alaupovic, P., & Brewer, H. B. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00200-9 · Cited by 15
[10] Quantitation of apolipoprotein E
Krul, E. S., & Cole, T. G. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)63012-2 · Cited by 9
Metadata
- Authors
- Tall, A. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1990-08-01
- Volume
- 86
- Issue
- 2
- Pages
- 379-384
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2048978769
- Cited by
- 652
- References
- 41
- FWCI
- 42.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.